About 15 years ago, the FDA briefly granted the peptide an orphan-drug designation, which provides incentives to a developer to work on therapies for diseases that affect fewer than 200,000 people in the U.S
The trend recently caught the attention of the FDA, which has added more than two dozen peptides to an interim list of substances that should not be compounded due to safety concerns
TB-500 acts systemically, mobilizing stem cells, suppressing inflammatory cytokines, and regulating actin for tissue remodeling
sterile and free from pyrogens Classification: Sterile bacteriostatic aqueous solution for laboratory or research use Storage: Store at room temperature in a tightly closed container
A 2018 paper in Current Pharmaceutical Design (Seiwerth S et al.) reviewed BPC-157's observed effects on angiogenesis the formation of new blood vessels and its potential role in tissue healing processes
Gave me a little bit of energy